TRANSFORMING growth factor-beta (TGF-β) inhibits cell proliferation by inducing a Gl-phase cell cycle arrest1. Normal progression through Gl is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced ∼30-fold in human keratinocytes by treatment with TGF-β, suggesting that pi5 may act as an effector of TGF-β-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Massague, J. A. Rev. Cell Biol. 6, 597–641 (1990).
Sherr, C. J. Cell 73, 1059–1065 (1993).
Bates, S. et al. Oncogene 9, 71–79 (1994).
Meyerson, M. & Harlow, E. Molec. cell. Biol. 14, 2077–2086 (1994).
Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M. & Massague, J. Cell 62, 175–185 (1990).
Pietenpol, J. et al. Cell 61, 777–785 (1990).
Boukamp, P. et al. J. Cell Biol. 106, 761–771 (1988).
Geng, Y. & Weinberg, R. A. Proc. natn. Acad. Sci. U.S.A. 90, 10315–10319 (1993).
Serrano, M., Hannon, G. J. & Beach, D. Nature 366, 704–707 (1993).
Kamb, A. et al. Science 264, 436–440 (1994).
Ewen, M. E., Sluss, H. K., Whitehouse, L. L. & Livingston, D. M. Cell 74, 1009–1020 (1993).
Polyak, K. et al. Cell 78, 59–66 (1994).
Toyoshima, H. & Hunter, T. Cell 78, 67–74 (1994).
Polyak, K. et al. Genes Dev. 8, 9–22 (1994).
Bello, M. J., et al. Genes Chromosomes Cancer 9, 33–41 (1994).
Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
Fountain, J. E. et al. Proc. natn. Acad. Sci. U.S.A. 89, 10557–10561 (1992).
Cannon-Albright, L. A. et al. Science 258, 1148–1152 (1992).
Nobori, T. et al. Nature 368, 753–756 (1994).
Xiong, Y., Zhang, H. & Beach, D. Genes Dev. 7, 1572–1583 (1993).
Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
Masui, T. et al. Proc. natn. Acad. Sci. U.S.A. 83, 2438–2442 (1986).
Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Hannon, G. J., Demetrick, D. & Beach, D. & Beach, D. Genes Dev. 7, 2378–2391 (1993).
Xiong, Y. et al. Nature 366, 701–704 (1993).
Rights and permissions
About this article
Cite this article
Hannon, G., Beach, D. pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest. Nature 371, 257–261 (1994). https://doi.org/10.1038/371257a0
This article is cited by
Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource
Genome Biology (2022)
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
Nature Reviews Urology (2022)
Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2
Scientific Reports (2022)
Asian-specific 3’UTR variant in CDKN2B associated with risk of pituitary adenoma
Molecular Biology Reports (2022)
Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis
BMC Medical Genomics (2021)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.